To date, the FDA had required that all batches of Botox be tested on mice in order to ensure that they are all consistently safe and efficient. For the last ten years, the company has been working on an alternative testing method, one that relied on cells in a culture ("in vitro" testing) rather than laboratory animals. The FDA finally approved this testing method, and Allergan plans to phase it in over the next three years.